AnaptysBio, Inc.
ANAB
$17.17
$0.935.73%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 385.37M | 430.12M | 350.80M | 354.67M | 390.90M |
| Total Receivables | 40.77M | 12.20M | 9.01M | 7.09M | 6.85M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.74M | 6.37M | 7.54M | 10.67M | 9.08M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 431.88M | 448.68M | 367.35M | 372.42M | 406.84M |
|
|
|||||
| Total Current Assets | 431.88M | 448.68M | 367.35M | 372.42M | 406.84M |
| Net Property, Plant & Equipment | 16.23M | 16.57M | 17.12M | 17.69M | 18.27M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 256.00K | 256.00K | 256.00K | 256.00K | 256.00K |
| Total Assets | 483.83M | 493.42M | 427.38M | 405.84M | 452.39M |
|
|
|||||
| Total Accounts Payable | 4.00M | 3.59M | 4.89M | 4.58M | 4.70M |
| Total Accrued Expenses | 39.50M | 37.95M | 33.22M | 25.45M | 30.51M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.93M | 1.89M | 1.85M | 1.81M | 1.78M |
| Total Finance Division Other Current Liabilities | -- | 456.00K | 456.00K | 456.00K | 456.00K |
| Total Other Current Liabilities | -- | 456.00K | 456.00K | 456.00K | 456.00K |
| Total Current Liabilities | 45.43M | 43.88M | 40.42M | 32.30M | 37.44M |
|
|
|||||
| Total Current Liabilities | 45.43M | 43.88M | 40.42M | 32.30M | 37.44M |
| Long-Term Debt | 353.43M | 350.56M | 361.98M | 310.18M | 310.81M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 14.11M | 14.61M | 15.10M | 15.58M | 16.04M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 412.97M | 409.05M | 417.50M | 358.06M | 364.29M |
|
|
|||||
| Common Stock & APIC | 829.89M | 821.15M | 714.99M | 706.43M | 703.00M |
| Retained Earnings | -759.33M | -737.54M | -704.69M | -658.03M | -614.10M |
| Treasury Stock & Other | 305.00K | 759.00K | -415.00K | -624.00K | -797.00K |
| Total Common Equity | 70.87M | 84.37M | 9.88M | 47.78M | 88.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 70.87M | 84.37M | 9.88M | 47.78M | 88.10M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 70.87M | 84.37M | 9.88M | 47.78M | 88.10M |
|
|
|||||
